Catastrophic Medical Expenses: A Comorbidity Requiring Multilevel Intervention
Abstract
Catastrophic medical expenses are a significant yet often overlooked comorbidity, particularly in low- and middle-income countries like India. This article examines the causes, consequences, and potential solutions to mitigate the financial burden of healthcare.
Hospitalisation costs, especially for uninsured individuals, can lead to severe financial distress, pushing families into poverty. High-interest loans, often taken to settle medical bills, further exacerbate the crisis, compromising the nutritional, educational, and healthcare needs of vulnerable family members. This sets off a vicious circle of poverty and ill-health.
Public awareness and sensitisation of healthcare providers are critical, as uncompromising adherence to expensive investigation and treatment protocols may inadvertently contribute to financial ruin among vulnerable patients.
Motor vehicle accidents, a major public health issue, are a leading cause of catastrophic expenses. Young adults are frequent victims. Unfortunately they are often uninsured due to perceived low risk. Human error accounts for over 80% of road injuries, underscoring the need for public education on safe road behaviour. Lifestyle factors like tobacco and alcohol use also contribute to severe health conditions, emphasising the importance of preventive measures such as regular exercise, balanced diets, and early detection through screening.
The dilemma of ICU admissions for patients with poor prognosis highlights the need for ethical and financial sensitisation among healthcare providers. Social pressure often leads to futile ICU admissions and unaffordable treatments. Doctors must balance clinical guidelines with families’ financial realities, guiding them toward cost-effective alternatives when appropriate.
Inadequate insurance coverage and frequent claim rejections further compound the issue. Government-sponsored schemes like Ayushman Bharat Yojana aim to provide financial protection, but challenges persist. Strategies to reduce claim rejections include enhancing data accuracy, verifying eligibility, and leveraging technology.
In conclusion, addressing catastrophic medical expenses requires multilevel interventions, including public awareness, provider sensitisation, preventive healthcare, and robust insurance systems, to ensure financial protection and universal health coverage.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
When publishing with Kerala Medicial Journal (KMJ), authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Work includes the material submitted for publication and any other related material submitted to KMJ. In the event that KMJ does not publish said work, the author(s) will be so notified and all rights assigned hereunder will revert to the author(s).
The assignment of rights to KMJ includes but is not expressly limited to rights to edit, publish, reproduce, distribute copies, include in indexes or search databases in print, electronic, or other media, whether or not in use at the time of execution of this agreement.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
The author(s) hereby represents and warrants that they are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work based on substantially similar data has been submitted to another publication.